期刊文献+

替吉奥及MDSCs靶向干预剂对胆囊癌肿瘤微环境的影响 被引量:3

Influence of S-1 and MDSCs targeted intervention agent on gallbladder tumor microenvironment
原文传递
导出
摘要 目的 探讨化疗药物替吉奥和维生素D3等髓源性抑制细胞(MDSCs)靶向干预药物对胆囊癌肿瘤微环境的影响,为替吉奥及MDSCs靶向干预剂用于胆囊癌的临床治疗提供理论依据.方法 体外培养人胆囊癌细胞系NOZ,建立人源性胆囊癌裸鼠荷瘤动物模型,应用靶向干预MDSCs药物,运用流式细胞术筛选、鉴定、定量分析肿瘤组织微环境中MDSCs.结果 药物干预实验显示,对照组肿瘤组织平均体积大小2 246.4 mm3,而替吉奥组则为62.4 mm3,差异具有统计学意义(P<0.05),说明替吉奥能够明显抑制肿瘤细胞组织的生长,但对胆囊癌微环境中的MDSCs的影响微小.维生素D3组MDSCs表达比例为1.6%、COX-2抑制剂为1.6%,较对照组4.7%明显减少且差异具有统计学意义(P<0.05),说明维生素D3、COX-2抑制剂均能够明显降低胆囊癌微环境中MDSCs细胞的表达.在脾脏组织中,MDSCs亦呈相同变化趋势,其中维生素D3靶向干预效果更为明显.结论 靶向干预胆囊癌微环境中MDSCs表达能够改善肿瘤免疫逃逸状态,提示替吉奥化疗方案联合应用MDSCs靶向干预药物治疗胆囊癌具有可行性. Objective To explore the effect on the gallbladder tumor microenvironment of chemotherapy drugs (gimeracil and oteracil porassium) S-1 and MDSCs targeted intervention drug such as vitamin D3 etc.To provide theoretical basis for clinical treatment of gallbladder cancer with S-1 in conjunction with MDSCs targeted intervention drugs.Methods Using the in vitro cultured human gallbladder cancer cells NOZ to establish anthropogenic tumor-burdened gallbladder cancer nude mice animal model,application of MDSCs drugs targeted intervention,using flow cytometry screening,identification and quantitative analysis of MDSCs in tumor microenvironment.Results Drug intervention trials showed that the mean tumor size of the control group was 2 246.44 mm3,while Gimeracil and Oteracil Porassium Capsules group was 62.40 mm3,and the difference was statistically significant (P 〈 0.05),which showed that Gimeracil and Oteracil Porassium Capsules could significantly inhibit the growth of tumor cells and tissues,but its effect on MDSCs in the gallbladder microenvironment was slight; MDSCs expression ratio in vitamin D3 group was 1.6%,and COX-2 inhibitor group was 1.6%,compared with control group (4.7%),the ratio decreased significantly,and the difference was statistically significant (P 〈 0.05),which indicated that vitamin D3 and COX-2 inhibitors were able to reduce the expression of MDSCs cells in gallbladder cancer microenvironment significantly (P 〈 0.05).In the spleen tissues,similar trend of MDSCs were also presented,while the the effect was more apparent in vitamin D3 targeted intervention group.Conclusions Targeted intervention the expression of MDSCs in gallbladder cancer microenvironment can improve state of tumor immune escape.S-1 in conjunction with MDSCs targeted intervention chemotherapy drugs in the treatment of the tumor of gallbladder is feasible.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2015年第5期337-341,共5页 Chinese Journal of Hepatobiliary Surgery
基金 国家自然科学基金(81472280) 上海市科委“科技支撑项目”基金(13140902902)
关键词 胆囊癌 髓源性抑制细胞 替吉奥 维生素D3 COX-2抑制剂 Gallbladder Cancer Myeloid-derived suppressor cells Tegafur Vitamin D3 Cox-2 inhibitors
  • 相关文献

参考文献22

  • 1Torte LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2) :87-108.
  • 2Ylsing AW, Gao YT, Han TQ, et al. Gallstones and the risk of biliary tract cancer: a population-based study in China[J]. Br J Cancer, 2007,97 ( 11 ) : 1577-1582.
  • 3Watanabe M, Yamazaki K, Yajima S, et 81. Fourteen-years of di- sease-free survival in a patient with advanced gallbladder carcinoma after radical resection : a case report [ J ]. Hepatogastroenterology, 2009,56 (90) :335-338.
  • 4慎浩鑫,宋虎伟,陈晨,马丽,赵亚玲,马建仓,耿西林,张小弟,王钢,姬乐,郝琪伟,杨瑞,唐洪涛,刘安选,杨成林,董山潮,王林,耿智敏.陕西省2009-2013年胆囊癌临床流行病学调查报告[J].中华肝胆外科杂志,2015,21(1):5-8. 被引量:19
  • 5Brown JM. Tumor microenvironment and the response to anticancer therapy [ J ]. Cancer Biol Ther, 2002,1 ( 5 ) :453-458.
  • 6束翌俊,翁昊,包润发,吴向嵩,丁倩,李茂岚,江林,胡云平,谈竹君,刘颖斌.Cariporide对胆囊癌细胞株GBC—SD转移及基质金属蛋白酶表达的影响[J].中华肝胆外科杂志,2014,20(6):467-472. 被引量:4
  • 7何向锋,窦骏.髓源性抑制细胞在肿瘤免疫中的作用[J].微生物学免疫学进展,2009,37(2):64-67. 被引量:2
  • 8刘秋燕,曹雪涛.MDSCs与肿瘤免疫逃逸[J].中国肿瘤生物治疗杂志,2009,16(4):319-324. 被引量:23
  • 9Morizane C, Okusaka T, Mizusawa J, et al. Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial ( JCOG 0805 ) [ J ]. Cancer Sci, 2013,104(9) : 1211-1216.
  • 10Vincent J, Mignot G, Chalmin F, et al. 5-Fluomuracil selectively kills tumor-associated myeloid-derived suppressor ceils resulting in enhanced T cell-dependent antitumor immunity[J]. Cancer Res, 2010,70(8) :3052-3061.

二级参考文献106

  • 1崔彦,黄仲初.原发性胆囊癌:国内文献1281例分析[J].普外临床,1989,4(3):180-181. 被引量:44
  • 2张铭琏,余云.胆囊癌714例诊治综合分析报告[J].中国实用外科杂志,1995,15(1):30-33. 被引量:61
  • 3Gabrilovich D, Bronte V, Chen S-H, et al. The terminology issue for myeloid-derived suppressor cells [ J ]. Cancer Res 2007,67 : 425.
  • 4Zea AH, Rodriguez PC. Arglnase-producing myeloid suppressor cells in renal cell carcinoma patients: a mcchanism of tumor evasion[J]. Cancer Res 2005,65(8) :3044- 3048.
  • 5Li Y, Koari F, Laura M D, et al. Expansion of myeloid immune suppressor Gr + CDIIb + cells in tumor-bearing host directly promotes tumor angiogenesis[J]. Cancer Cell 2004,6(4) :409- 421.
  • 6Yang R, Cai Z, Zhang Y, et al. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1 + CDI lb + myeloid cells [ J ]. Cancer Res 2006,66 ( 13 ) :6807- 6815.
  • 7Liu Y, Zeng B, Zhang Z, et al. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer[ J]. Clin Immunol 2008,129 (3) :471- 481.
  • 8Movahedi K, GniLllams M, Van den Bcssche J,et al. Identification of discrete tumor-induced rnyeloid-derived suppressor cell subpopulations with distinct T cell suppressive activity [ J ]. Blood 2008,111(8) :4233-4244.
  • 9Youn Jl, Nagaraj S, Collazo M, et al. Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice [ J ]. The Journal of Immunology 2008,181 : 5791- 5802.
  • 10Rodrlguez PC, Quiceno DG, Ochoa AC. L-arglnine availability regulaes T-lymphocyte cell-cycle progression [ J ]. Blood 2007,109 (4) :1568-1573.

共引文献43

同被引文献27

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部